Abstract # 1012 Impact Of The New WHO Classification On Decision-making For Radiation Therapy In Patients With Atypical And Anaplastic Meningiomas

Presenter: Stephanie Combs, MD

About the Presenter:
Dr. Stephanie E. Combs is a Board-Certified Radiation Oncologist at the Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany. She earned her MD at the University of Heidelberg, with special training at the UTHSCSA in San Antonio, TX and EVMS in Norfolk, Virginia. She is head of the Neuro-Radiation Oncology Research Group at the Department, and is a member of the interdisciplinary Neuro-Oncology Team at the University Hospital of Heidelberg together with the Departmments of Neurooncology, Neurosurgery, Neuropathology and Neuroradiology. Dr. Combs has her main research focus on clinical and experimental Neuro-Oncology, Pediatric Oncology, and the implementation of innovative high-tech radiation oncology into clinical routine. She is a member of the Particle Therapy Team at the Heidelberg Ion Therapy Center (HIT) under the Lead of Prof. Dr. Dr. Jürgen Debus, and has performed clinical and preclinical studies on the role of carbon ion radiotherapy. Dr. Combs has published more than 40 peer-reviewed manuscripts, and serves as a reviewer in several scientific journals. She is a member of the Particle Therapy Cooperative Group (PTCOG), the American Society of Clinical Oncology (ASCO), The German Cancer Society and the German Society for Radiation Oncology.
Contact the presenter at: stephanie.combs@med.uni-heidelberg.de


E-mail a friend about this poster:
Enter email address: